IRESSA 250 mg film-coated tablets *
Pharmacy Only: Prescription
Show product notice

  • Company:

    AstraZeneca Pharmaceuticals (Ireland) DAC
  • Status:

    No Recent Update
  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)
  • Active Ingredient(s):

    *Additional information is available within the SPC or upon request to the company

Summary of Product Characteristics last updated on 19/1/2023 Download PDF

Product Notice

Discontinued Strength Notice

Supply of Iressa 250mg film-coated tablets to the Irish market will be discontinued by end June 2023.